Synthace
Patrick Zhang is an investor at Horizons Ventures, where he primarily covers biotechnology and healthcare investments, and manages related portfolio companies for Horizons. He was trained as a chemical engineer and worked in a variety of organizations across industries including power utilities, financial services and investment management.
Prior to Horizons, Patrick was an investment banker with Morgan Stanley providing financial advisory services on capital raising and cross-border M&A to his clients.
Mr. Zhang received his BS degree in Chemical Engineering from UCLA and MBA from Columbia Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Synthace
5 followers
Synthace's goal is to raise universal bioscience productivity, enabling people to better engineer biology for health, food, energy and manufacturing. Central to its technology is Antha, an operating system for biology that enables ease of designing and optimizing biological unit operations that are linked into executable workflows that are reliable, shareable and scalable. Antha spreads biological information in a repeatable way, linking lab equipment, protocols and processes, thereby allowing vast and speedy development, enhancing productivity for any bioscience.